Galenica Aktie 36067446 / CH0360674466
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
21.10.2025 07:55:04
|
Galenica strengthens basic care with new pharmacy concept
Galenica AG
/ Key word(s): Product Launch
Press release
Around 1,830 public pharmacies ensure nationwide basic care in Switzerland – more than 300,000 people visit a pharmacy every day. In addition to dispensing medicines, pharmacies increasingly offer services such as vaccinations, health checks and advice for acute complaints. Demographic change and the strained medical supply situation mean that demand for these local easily accessible services continues to grow. Galenica develops new pharmacy conceptTo strengthen the role of pharmacies as a central point of contact for health issues, Galenica is working on new care models and the customer experience in pharmacies. A modernised Amavita pharmacy will open in Zurich’s Glattzentrum on 25 October 2025. It will serve as a pilot for a new pharmacy concept that more closely links consultation, store design and digital support. With the launch, Galenica is fundamentally redesigning the customer experience and showing what pharmacies can look like in the future.
The redesigned pharmacy offers express checkouts for quick shopping, fully private rooms for discreet consultations and new semi-private consultation areas. Here, specialists and customers can compare and discuss products and services together on screens. In doing so, Galenica is also responding to changing customer needs: Today, around 80% of customers first obtain information online before visiting a pharmacy. Galenica has been making targeted investments in connecting digital and in-store offerings for several years. The new pharmacy concept is a key component of this strategy.
“As Switzerland’s strongest healthcare network, we want to participate in shaping the role of pharmacies in health and care. To this end, we are investing specifically in modern space concepts, digitalisation, new offers and the further development of employees’ skills,” says Marc Werner, CEO of Galenica. Further pharmacies based on the new concept planned for 2026With “Consultation plus,” pharmacies in the Galenica network already offer an easily accessible advisory service, for example for acute concerns such as bladder problems or skin problems as well as preventive health checks such as HerzCheck®. Depending on cantonal regulations, Amavita and Sun Store pharmacies also offer different vaccinations. With the “Cost containment package 2,” the federal government is also underlining the competencies of the pharmacy.
The pharmacy in Glattzentrum is a pilot project that will be implemented with existing staff. Galenica gains insights into customer behaviour, processes and training needs, which are incorporated directly into the further development of the pharmacies. Additional pilot pharmacies are planned for 2026 – as the next step towards broader implementation at other locations.
Dates for the diary
For further information, please contact:
Welcome to the Galenica network!
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Find out more about Galenica at www.galenica.com.
End of Media Release |
Language: | English |
Company: | Galenica AG |
Untermattweg 8 | |
3027 Bern | |
Switzerland | |
Phone: | +41 058 852 81 11 |
E-mail: | info@galenica.com |
Internet: | https://www.galenica.com |
ISIN: | CH0360674466 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2215604 |
End of News | EQS News Service |
|
2215604 21.10.2025 CET/CEST
Nachrichten zu Galenica AG
16:29 |
Galenica Aktie News: Galenica am Dienstagnachmittag im Plus (finanzen.ch) | |
12:29 |
Galenica Aktie News: Galenica verteidigt am Dienstagmittag Tendenz (finanzen.ch) | |
09:29 |
Galenica Aktie News: Galenica verteidigt am Vormittag Vortagesniveau (finanzen.ch) | |
07:55 |
Galenica stärkt Grundversorgung mit neuem Apothekenkonzept (EQS Group) | |
07:55 |
Galenica strengthens basic care with new pharmacy concept (EQS Group) | |
08.10.25 |
SPI-Wert Galenica-Aktie: So viel hätten Anleger an einem Galenica-Investment von vor 5 Jahren verdient (finanzen.ch) |
Gold auf Allzeithoch, Dollar unter Druck: Kippt jetzt der KI-Hype?
Gold auf Allzeithoch, US-Dollar unter Druck, KI-Hype, US-Schuldenkrise, Stagflation, Zinswende, Government Shutdown, steigende Anleiherenditen, Europa in der Zinsfalle (Frankreich, UK), Japan hebt Leitzinsen an, Immobilien- & Aktienblase in den USA, Notenbanken kaufen Gold.
Im Interview analysiert Marco Ludescher (Dr. Blumer & Partner Vermögensverwaltung Zürich) die Lage an den Kapitalmärkten. Olivia Hähnel (BX Swiss) hakt nach: Was bedeutet die Goldrally für Anleger? Kippt der KI-Hype? Wie wirken Schulden, Inflation und Zinspolitik auf Aktien, Anleihen und Immobilien?
Überblick:
– Gold & Währungen: Rekord-Gold vs. schwacher US-Dollar (DXY).
– Makro & Zinsen: Zinswende der Notenbanken vs. steigende Marktrenditen; Stagflations-Risiko.
– USA-Fokus: Defizite, Shutdown, Konsumdruck, Immobilienmarkt, Tech-Bewertungen.
– Europa: Frankreich & UK unter Druck; Emissionen, Hypotheken, Unternehmenslage.
– Japan: Ende der Ultra-Niedrigzinsen? YCC-Folgen für Yen & Renditen.
– KI & Tech: Investitionswelle (Nvidia, OpenAI, Oracle, CoreWeave, Meta, Amazon) – Chance oder KI-Blase?
– Takeaways: Rolle von Edelmetall-Produzenten, Diversifikation, schrittweises Vorgehen.
👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Hoffnung im Handelskonflikt: SMI schliesst wenig bewegt -- DAX letztlich höher -- Börsen in Asien beenden Handel mit GewinnenAm heimischem Aktienmarkt zeigten sich am Dienstag letztlich nur marginale Verluste. Der deutsche Aktienmarkt kämpfte sich unterdessen in die Gewinnzone zurück. Die US-Börsen notieren uneins. In Fernost dominierten am Dienstag die Käufer.